183 related articles for article (PubMed ID: 8946950)
1. The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity.
Wilmen A; Göke B; Göke R
FEBS Lett; 1996 Nov; 398(1):43-7. PubMed ID: 8946950
[TBL] [Abstract][Full Text] [Related]
2. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.
López de Maturana R; Willshaw A; Kuntzsch A; Rudolph R; Donnelly D
J Biol Chem; 2003 Mar; 278(12):10195-200. PubMed ID: 12524435
[TBL] [Abstract][Full Text] [Related]
3. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
Al-Sabah S; Donnelly D
Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
[TBL] [Abstract][Full Text] [Related]
4. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
5. Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function.
Van Eyll B; Göke B; Wilmen A; Göke R
Peptides; 1996; 17(4):565-70. PubMed ID: 8804062
[TBL] [Abstract][Full Text] [Related]
6. The amino terminal domain of the glucagon-like peptide-1 receptor is a critical determinant of subtype specificity.
Graziano MP; Hey PJ; Strader CD
Recept Channels; 1996; 4(1):9-17. PubMed ID: 8723643
[TBL] [Abstract][Full Text] [Related]
7. Five out of six tryptophan residues in the N-terminal extracellular domain of the rat GLP-1 receptor are essential for its ability to bind GLP-1.
Wilmen A; Van Eyll B; Göke B; Göke R
Peptides; 1997; 18(2):301-5. PubMed ID: 9149304
[TBL] [Abstract][Full Text] [Related]
8. In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor.
Bazarsuren A; Grauschopf U; Wozny M; Reusch D; Hoffmann E; Schaefer W; Panzner S; Rudolph R
Biophys Chem; 2002 May; 96(2-3):305-18. PubMed ID: 12034449
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.
Underwood CR; Garibay P; Knudsen LB; Hastrup S; Peters GH; Rudolph R; Reedtz-Runge S
J Biol Chem; 2010 Jan; 285(1):723-30. PubMed ID: 19861722
[TBL] [Abstract][Full Text] [Related]
10. The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge.
López de Maturana R; Donnelly D
FEBS Lett; 2002 Oct; 530(1-3):244-8. PubMed ID: 12387900
[TBL] [Abstract][Full Text] [Related]
11. Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.
Runge S; Wulff BS; Madsen K; Bräuner-Osborne H; Knudsen LB
Br J Pharmacol; 2003 Mar; 138(5):787-94. PubMed ID: 12642379
[TBL] [Abstract][Full Text] [Related]
12. Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo.
Xiao Q; Giguere J; Parisien M; Jeng W; St-Pierre SA; Brubaker PL; Wheeler MB
Biochemistry; 2001 Mar; 40(9):2860-9. PubMed ID: 11258897
[TBL] [Abstract][Full Text] [Related]
13. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
[TBL] [Abstract][Full Text] [Related]
14. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma.
Volz A; Göke R; Lankat-Buttgereit B; Fehmann HC; Bode HP; Göke B
FEBS Lett; 1995 Oct; 373(1):23-9. PubMed ID: 7589426
[TBL] [Abstract][Full Text] [Related]
16. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
[TBL] [Abstract][Full Text] [Related]
17. The positive charge of the imidazole side chain of histidine7 is crucial for GLP-1 action.
Hareter A; Hoffmann E; Bode HP; Göke B; Göke R
Endocr J; 1997 Oct; 44(5):701-5. PubMed ID: 9466326
[TBL] [Abstract][Full Text] [Related]
18. Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes.
Hjorth SA; Adelhorst K; Pedersen BB; Kirk O; Schwartz TW
J Biol Chem; 1994 Dec; 269(48):30121-4. PubMed ID: 7527026
[TBL] [Abstract][Full Text] [Related]
19. Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling.
Unson CG; Wu CR; Jiang Y; Yoo B; Cheung C; Sakmar TP; Merrifield RB
Biochemistry; 2002 Oct; 41(39):11795-803. PubMed ID: 12269822
[TBL] [Abstract][Full Text] [Related]
20. Characterization of glucagon-like peptide-1 receptor-binding determinants.
Xiao Q; Jeng W; Wheeler MB
J Mol Endocrinol; 2000 Dec; 25(3):321-35. PubMed ID: 11116211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
